ThursdayJan 05, 2023 1:15 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Secures Stream of Steady Business on Fr8App Platform

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a company specializing in creating and providing supply chain optimization and automation solutions, and Freight App Inc. (“Fr8App”), its wholly owned subsidiary, have always sought to create offerings that contribute to their clients’ success by improving efficiency and profitability. “Designed to help solve shippers’ needs to secure freight capacity over time rather than on a trip-by-trip basis and guarantee carriers a steady stream of revenue, Fr8PrivateFleet matches carriers with the capacity for predetermined amount of load over a stated period with shippers… The advantages of Fr8PrivateFleet persuaded new and existing Fr8App customers to integrate it…

Continue Reading

WednesdayJan 04, 2023 1:36 pm

TinyGemsBreaks – Vision Energy Corp.’s (VENG) Pioneering Terminal Set to Accelerate Energy Transition

Vision Energy (OTCQB: VENG) recently entered into a corporation agreement with Linde Engineering to accelerate efforts for the company’s pioneering Green Energy Terminal in the North Sea Port of Vlissingen, the Netherlands. “Linde Engineering, a leading global industrial gases and engineering company with 2021 sales of $31 billion, will deliver preliminary Front-End Engineering and Design (‘FEED’) services to the project including design and engineering of 150,000 cubic meters (‘CBM’) of green ammonia (‘NH3’) storage, truck and barge loading facilities, ship loading and unloading facilities, as well as utilities, infrastructure and buildings… Vision Energy is in the advanced stages of planning…

Continue Reading

FridayDec 16, 2022 3:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (‘CBD’) may potentially have therapeutic utility against diabetes,” a recent article reads. “Lexaria is optimistic that its DehydraTECH-CBD will yield notable results from this study, especially having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study. There is a strong connection between heart disease, hypertension and diabetes, with hypertension proving to…

Continue Reading

WednesdayDec 14, 2022 2:14 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Committed to Driving Berubicin Program Forward

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments, recently announced that the first patient in Europe had been enrolled and dosed in France in the company’s ongoing global trial to evaluate Berubicin for the treatment of recurrent glioblastoma multiforme (“GMB”), an aggressive and incurable form of brain cancer. “Berubicin is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier (based upon pre-clinical and limited clinical data) and is currently being evaluated in the potentially pivotal study evaluating efficacy and safety for GBM treatment. This study is an adaptive,…

Continue Reading

WednesdayDec 14, 2022 2:03 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Well Funded to Scale Lidar Technology for Mass Deployment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently entered into a binding agreement for a $100 million investment from Koito Manufacturing Co., Ltd., its long-term automotive tier 1 partner and current shareholder. Cepton “intends to use this investment – Koito’s third since 2020 – to fund the company’s next growth stage as it looks to execute its vision to scale lidar technology for mass deployment… Cepton and Koito have had an established history of collaboration, including one that has been crowned with notable success, such as a significant ADAS lidar series production award on…

Continue Reading

MondayDec 12, 2022 12:45 pm

TinyGemsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) B2B Marketplace Offers Real-Time Portal to Connect Shippers, Carriers

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process, provides a platform for B2B cross-border shipping across the USMCA (U.S.-Mexico-Canada) region. “The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping,” a recent article reads. “Fr8Tech is leveraging its technology to help improve its customers’ operational efficiency and security while reducing its carbon footprint by optimizing empty miles and reducing paper consumption. Fr8App is a cloud-based marketplace that combines all aspects…

Continue Reading

ThursdayDec 08, 2022 1:46 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Latest DehydraTECH-CBD Study May Be 1st to Evidence Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs, has, since inception, been committed to addressing severe unmet patient needs. Hypertension has been one of its main focus areas. “Lexaria continues to move forward, most recently with the success in its latest human clinical study, HYPER-H21-4. The study may be the first to evidence a sustained drop in blood pressure in normally active patients following multiple weeks of oral cannabidiol (‘CBD’) therapy using the company’s patented DehydraTECH(TM) technology,” reads a recent article. “Since Lexaria began developing DehydraTECH…

Continue Reading

FridayDec 02, 2022 1:48 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking Lidar Mainstream, Enabling World’s Leading Automotive Companies to Integrate at Scale

Cepton (NASDAQ: CPTN) is a Silicon Valley innovator of lidar-based solutions for autonomous vehicle (“AV”) and advanced driver assistance system (“ADAS”) sectors. “Cepton leads the way in enabling the world’s leading automotive companies to integrate lidar at scale and transition to an increasingly adaptive, safety-centric future. Safety is at the forefront of ADAS/AV technology concerns, and the industry’s success hinges on the availability of perception solutions that accurately identify objects under various conditions… Dr. Jun Pei, CEO and co-founder of Cepton, believes lidar brings unparalleled vehicle perception by ‘seeing’ things in 3D instead of the standard 2D view produced by…

Continue Reading

WednesdayNov 23, 2022 3:26 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for glioblastoma multiforme (‘GBM’), according to CNS Pharmaceuticals CEO John Climaco. The company’s focus and priorities, Climaco emphasized, are firmly anchored in the advancement of its clinical development for its drug candidate Berubicin with the aim of bringing meaningful treatment to GBM patients. And as he separately told attendees at…

Continue Reading

WednesdayNov 23, 2022 2:17 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)

Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept to deployment. “With this collaboration, Cepton seeks to accelerate the development of lidar solutions for assisted and autonomous driving for global consumers. NVIDIA DRIVE Sim simulations enable automakers and developers to work with Cepton’s lidar models in a virtual environment to identify suitable Cepton lidar sensors for specific application needs and integrate them with other sensor technologies, such as camera and radar. They can prototype…

Continue Reading

Contact us: (310) 299-1717